Consainsights logo

High Throughput Screening Market Size, Share, Industry Trends and Forecast to 2030

High Throughput Screening Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

High Throughput Screening Market Size & CAGR

The global high throughput screening market is anticipated to exhibit a steady growth rate with a CAGR of 4.5% from 2021 to 2026. The market size is expected to reach USD 27.3 billion by 2026, showing promising growth opportunities in the coming years.

COVID-19 Impact on the High Throughput Screening Market

The COVID-19 pandemic has significantly impacted the high throughput screening market. With the focus on developing vaccines and treatments for the virus, there has been a surge in the demand for high throughput screening technologies to expedite the drug discovery process. The market witnessed a spike in investments in research and development activities aimed at combating the pandemic, leading to an increased adoption of high throughput screening solutions.

High Throughput Screening Dynamics

The high throughput screening market is driven by factors such as the growing prevalence of chronic diseases, increasing investment in drug discovery and development, and advancements in technology. The demand for high throughput screening techniques in the pharmaceutical and biotechnology industries is on the rise, as these techniques offer faster and more cost-effective drug discovery processes.

Segments and Related Analysis

The high throughput screening market is segmented based on technology, end user, and application. The technology segment includes cell-based assays, label-free technology, and others. The end user segment comprises pharmaceutical and biotechnology companies, academic & research institutes, and contract research organizations. The application segment covers drug discovery, toxicology assessment, and others.

By Region Analysis

The high throughput screening market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest market share due to the presence of key players, advanced healthcare infrastructure, and increasing R&D investments. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period.

Key Market Players and Competitive Landscape

Some of the key players in the high throughput screening market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., PerkinElmer, Inc., and Danaher Corporation. These companies are focusing on strategic initiatives such as product launches, collaborations, and acquisitions to strengthen their market presence and gain a competitive edge.

Recent Happenings in the High Throughput Screening Market

In recent developments, Thermo Fisher Scientific announced the launch of a new high throughput screening platform for drug discovery applications. The platform is designed to streamline the drug discovery process and accelerate the development of new therapies. Additionally, Agilent Technologies unveiled a cutting-edge high throughput screening system that offers enhanced performance and efficiency for pharmaceutical research.

Related Industries

    High-Throughput Screening (HTS) Market FAQs